Over the past two decades, the Polish CRO industry has transformed dramatically. What began with simple monitoring tasks has evolved into comprehensive offerings, covering full-process management, data analysis, and early-phase trials.
Today, the value of clinical trials in Poland stands at approximately €1.5 billion, contributing to an overall European market of around €12 billion, which is growing steadily at a rate of 5–6% year-on-year.
Thanks to private investments and robust scientific infrastructure, Poland and the CEE region have established a compelling position in global clinical research. Their emergence is a story of rapid evolution—from a supportive environment into a true innovation hub.
Marcel Zatoński (Puls Biznesu) helped highlight this transformation in a recent article. Don’t miss the full story: read the piece here (in Polish).
Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…
Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…
Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…
Copyright @ 2025 Axcellant